Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
3D Hydrogels Containing Interconnected Microchannels of Subcellular Size for Capturing Human Pathogenic Acanthamoeba Castellanii.
Gutekunst SB, Siemsen K, Huth S, Möhring A, Hesseler B, Timmermann M, Paulowicz I, Mishra YK, Siebert L, Adelung R, Selhuber-Unkel C. Gutekunst SB, et al. Among authors: mohring a. ACS Biomater Sci Eng. 2019 Apr 8;5(4):1784-1792. doi: 10.1021/acsbiomaterials.8b01009. Epub 2019 Jan 10. ACS Biomater Sci Eng. 2019. PMID: 30984820 Free PMC article.
[Cancer patients in the emergency department].
Liebregts T, Lueck C, Mohring A, Riße J, Tzalavras A. Liebregts T, et al. Among authors: mohring a. Med Klin Intensivmed Notfmed. 2024 Feb;119(1):3-9. doi: 10.1007/s00063-023-01055-2. Epub 2023 Sep 2. Med Klin Intensivmed Notfmed. 2024. PMID: 37659989 Review. German.
Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations.
Boquoi A, Rings V, Mohring A, Savickaite I, Zukovs R, Strapatsas J, Nachtkamp K, Kobbe G, Germing U, Fenk R. Boquoi A, et al. Among authors: mohring a. Cancers (Basel). 2022 Apr 26;14(9):2147. doi: 10.3390/cancers14092147. Cancers (Basel). 2022. PMID: 35565276 Free PMC article.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
23 results